147 related articles for article (PubMed ID: 38093893)
1. Retracted: Apatinib plus Radiotherapy on the Expression of CEA and VEGF in Advanced Oligometastatic Non-Small-Cell Lung Cancer.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9821932. PubMed ID: 38093893
[TBL] [Abstract][Full Text] [Related]
2. Retracted: Camrelizumab and Apatinib Combined with Radiotherapy Is Effective in Advanced Oligometastatic Non-Small-Cell Lung Cancer.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9826952. PubMed ID: 37387848
[TBL] [Abstract][Full Text] [Related]
3. Apatinib plus Radiotherapy on the Expression of CEA and VEGF in Advanced Oligometastatic Non-Small-Cell Lung Cancer.
Zhu Y; Lin Z; Wu C
Evid Based Complement Alternat Med; 2023; 2023():4242346. PubMed ID: 37089715
[TBL] [Abstract][Full Text] [Related]
4. Retracted: Clinical Efficacy of Osimertinib in Patients with Advanced Non-Small Cell Lung Cancer and Its Effect on Serum CEA and VEGF Expression.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9820926. PubMed ID: 38125182
[TBL] [Abstract][Full Text] [Related]
5. Retracted: Efficacy of Apatinib plus S-1 Therapy in the Treatment of Advanced Gastric Cancer Patients and the Effect on the Levels of Tumor Markers and Th1 and Th2-Like Cytokines.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9787205. PubMed ID: 38125103
[TBL] [Abstract][Full Text] [Related]
6. Camrelizumab and Apatinib Combined with Radiotherapy Is Effective in Advanced Oligometastatic Non-Small-Cell Lung Cancer.
Ye W; Song Z; Lin Z
Evid Based Complement Alternat Med; 2022; 2022():5067402. PubMed ID: 36193130
[TBL] [Abstract][Full Text] [Related]
7. Retracted: Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma.
International EM
Emerg Med Int; 2024; 2024():9795276. PubMed ID: 38298972
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment using apatinib with or without docetaxel in heavily pretreated advanced non-squamous non-small cell lung cancer: A case report and literature review.
Wu F; Zhang S; Gao G; Zhao J; Ren S; Zhou C
Cancer Biol Ther; 2018 Mar; 19(3):141-144. PubMed ID: 29261000
[TBL] [Abstract][Full Text] [Related]
9. Retracted: Effect of Apatinib Combined with Seggio on the Expression of Serum AFP and CA724 and Long-Term Survival Rate in Patients with Advanced Gastric Cancer Undergoing Comfortable Nursing Intervention.
Healthcare Engineering JO
J Healthc Eng; 2022; 2022():9756408. PubMed ID: 36530787
[TBL] [Abstract][Full Text] [Related]
10. Retracted: Efficacy, Safety, and Tumor Marker Inhibition of Apatinib Combined with Conventional Chemotherapy Regimens for Patients with Advanced Triple-Negative Breast Cancer.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9879023. PubMed ID: 37388035
[TBL] [Abstract][Full Text] [Related]
11. Retracted: The Role of Change Rates of CYFRA21-1 and CEA in Predicting Chemotherapy Efficacy for Non-Small-Cell Lung Cancer.
Methods In Medicine CAM
Comput Math Methods Med; 2023; 2023():9786104. PubMed ID: 37885855
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of the low dose apatinib plus deep hyperthermia as third-line or later treatment in HER-2 negative advanced gastric cancer.
Han G; Sun C; Cui L; Huang Y; Yu L; Liu S; Tao M
Pathol Oncol Res; 2023; 29():1611114. PubMed ID: 37465317
[No Abstract] [Full Text] [Related]
13. Efficacy and safety of apatinib alone or apatinib plus paclitaxel/docetaxel versus paclitaxel/docetaxel in the treatment of advanced non-small cell lung cancer: A meta-analysis.
Li Z; Liu Z; Wu Y; Li H; Sun Z; Han C; Zhang X; Zhang J
Thorac Cancer; 2021 Nov; 12(21):2838-2848. PubMed ID: 34622571
[TBL] [Abstract][Full Text] [Related]
14. Retracted: Correlation between the Expression of VEGF and Ki67 and Lymph Node Metastasis in Non-small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.
And Alternative Medicine EC
Evid Based Complement Alternat Med; 2023; 2023():9894125. PubMed ID: 38093895
[TBL] [Abstract][Full Text] [Related]
15. [Clinical study of apatinib combined with chemotherapy for advanced non-small cell lung cancer with negative driving genes].
Li YF; Jiang HY; Li Q; Zhu M; Lyu J; Zhao HY
Zhonghua Zhong Liu Za Zhi; 2019 Oct; 41(10):775-781. PubMed ID: 31648501
[No Abstract] [Full Text] [Related]
16. Apatinib monotherapy for advanced non-small cell lung cancer after the failure of chemotherapy or other targeted therapy.
Liu Z; Ou W; Li N; Wang SY
Thorac Cancer; 2018 Oct; 9(10):1285-1290. PubMed ID: 30126078
[TBL] [Abstract][Full Text] [Related]
17. Apatinib inhibits the growth of small cell lung cancer via a mechanism mediated by VEGF, PI3K/Akt and Ki-67/CD31.
Zhong N; Zhuang W; Huang Q; Wang Q; Jin W
J Cell Mol Med; 2021 Nov; 25(21):10039-10048. PubMed ID: 34590406
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of the Low Dose Apatinib plus Chemotherapy on Advanced Gastric Carcinoma.
Gao S; Li X; Shi W; Huo L; Liu H
J Oncol; 2022; 2022():3009494. PubMed ID: 35401748
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of camrelizumab plus apatinib as second-line treatment for advanced squamous non-small cell lung cancer.
Gao G; Zhao J; Ren S; Wang Y; Chen G; Chen J; Gu K; Guo R; Pan Y; Wang Q; Li W; Yang X; Zhou C
Ann Transl Med; 2022 Apr; 10(8):441. PubMed ID: 35571422
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of apatinib+radiotherapy
Pan H; Zhou X; Shen L; Li Y; Dong W; Wang S; Zhang Y; Pan W; Xie C; Cai X
Br J Radiol; 2023 Sep; 96(1149):20220550. PubMed ID: 37162165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
